Search research articles
Contact Us
Filters
Showing results (111-120 of 315) with videos related to
Page
of 32
Sort By:
Rapid Communications in Mass Spectrometry : RCM
|
August 31, 2006
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma
Javier Moreno-Farre, Yasmin Asad, Simon Pacey, et al.
Current Topics in Medicinal Chemistry
|
July 18, 2006
Discovery and development of pyrazole-scaffold Hsp90 inhibitors
Edward McDonald, Keith Jones, Paul A Brough, et al.
Journal of Biomolecular Screening
|
August 7, 2004
High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase
Chongbo Sun, Yvette Newbatt, Leon Douglas, et al.
Journal of Biomolecular Screening
|
November 10, 2006
Identification of novel keratinocyte differentiation modulating compounds by high-throughput screening
Masaru Honma, Mark Stubbs, Ian Collins, et al.
Cell Chemical Biology
|
June 2, 2021
Evolution of kinase polypharmacology across HSP90 drug discovery
Albert A Antolin, Paul A Clarke, Ian Collins, et al.
Anticancer Research
|
August 15, 2002
ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin
Vicki Smith, Stephen Hobbs, William Court, et al.
Molecular Cancer Research : MCR
|
July 30, 2015
Maximizing the Therapeutic Potential of HSP90 Inhibitors
Lisa M Butler, Roberta Ferraldeschi, Heather K Armstrong, et al.
Cancer Research
|
February 25, 2010
Drugging the PI3 kinome: from chemical tools to drugs in the clinic
Paul Workman, Paul A Clarke, Florence I Raynaud, et al.
Cancer Research
|
December 3, 2005
Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin
Silvy da Rocha Dias, Frank Friedlos, Yvonne Light, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 22, 2003
Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial
Yasmin Asad, Gillian Cropp, Alison Adams, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 315) with videos related to
Sort By:
Page
of 32
Rapid Communications in Mass Spectrometry : RCM
|
August 31, 2006
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma
Javier Moreno-Farre, Yasmin Asad, Simon Pacey, et al.
Current Topics in Medicinal Chemistry
|
July 18, 2006
Discovery and development of pyrazole-scaffold Hsp90 inhibitors
Edward McDonald, Keith Jones, Paul A Brough, et al.
Journal of Biomolecular Screening
|
August 7, 2004
High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase
Chongbo Sun, Yvette Newbatt, Leon Douglas, et al.
Journal of Biomolecular Screening
|
November 10, 2006
Identification of novel keratinocyte differentiation modulating compounds by high-throughput screening
Masaru Honma, Mark Stubbs, Ian Collins, et al.
Cell Chemical Biology
|
June 2, 2021
Evolution of kinase polypharmacology across HSP90 drug discovery
Albert A Antolin, Paul A Clarke, Ian Collins, et al.
Anticancer Research
|
August 15, 2002
ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin
Vicki Smith, Stephen Hobbs, William Court, et al.
Molecular Cancer Research : MCR
|
July 30, 2015
Maximizing the Therapeutic Potential of HSP90 Inhibitors
Lisa M Butler, Roberta Ferraldeschi, Heather K Armstrong, et al.
Cancer Research
|
February 25, 2010
Drugging the PI3 kinome: from chemical tools to drugs in the clinic
Paul Workman, Paul A Clarke, Florence I Raynaud, et al.
Cancer Research
|
December 3, 2005
Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin
Silvy da Rocha Dias, Frank Friedlos, Yvonne Light, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
January 22, 2003
Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial
Yasmin Asad, Gillian Cropp, Alison Adams, et al.
Page
of 32